Epstein Barr Virus

Epstein-Barr virus, frequently referred to as EBV, is a member of the herpesvirus family and one of the most common human viruses. The virus occurs worldwide, and most people become infected with EBV sometime during their lives.
Multiple Sclerosis and the Epstein Barr Virus

Epstein-Barr virus (EBV) is a herpes virus otherwise known of as human herpesvirus 4 (HHV-4). It is most well known for causing glandular fever but research shows that EBV infection is also linked to an increased risk for various autoimmune conditions including rheumatoid arthritis, dermatomyositis and multiple sclerosis.

Read More

Overview

Latest Epstein Barr Virus News and Research

Refining the diagnosis of large granular lymphocytic leukemias and their mimics

Refining the diagnosis of large granular lymphocytic leukemias and their mimics

Epstein-Barr virus triggers inflammatory cell death in ulcerative colitis

Epstein-Barr virus triggers inflammatory cell death in ulcerative colitis

Scientists reveal how Epstein-Barr virus reactivation triggers MIS-C in children

Scientists reveal how Epstein-Barr virus reactivation triggers MIS-C in children

Researchers identify cause of post-COVID inflammatory shock in children

Researchers identify cause of post-COVID inflammatory shock in children

Combination of Epstein-Barr virus antibodies and genes linked to increased risk of MS

Combination of Epstein-Barr virus antibodies and genes linked to increased risk of MS

Epstein-Barr virus infection predisposes people to develop Crohn's disease

Epstein-Barr virus infection predisposes people to develop Crohn's disease

Researchers identify MLC1 as potential target in multiple sclerosis

Researchers identify MLC1 as potential target in multiple sclerosis

Cancer-free for 18 years: CAR-T therapy sets new milestone in neuroblastoma treatment

Cancer-free for 18 years: CAR-T therapy sets new milestone in neuroblastoma treatment

The growing list of human viruses: Are we prepared for the next outbreak?

The growing list of human viruses: Are we prepared for the next outbreak?

Understanding infection risks in pediatric hematopoietic stem cell transplantation

Understanding infection risks in pediatric hematopoietic stem cell transplantation

New AI tool promises faster vaccine development by predicting T cell epitopes

New AI tool promises faster vaccine development by predicting T cell epitopes

Mapping the human virome to improve disease prevention and treatment

Mapping the human virome to improve disease prevention and treatment

Breakthrough in antigen recognition: TRACeR-I enhances immune targeting

Breakthrough in antigen recognition: TRACeR-I enhances immune targeting

Early exposure to parental smoking linked to higher MS risk

Early exposure to parental smoking linked to higher MS risk

Air pollution linked to head and neck cancer risk

Air pollution linked to head and neck cancer risk

VANCE trial marks milestone in t cell therapy for solid tumors

VANCE trial marks milestone in t cell therapy for solid tumors

Elevated antibody responses to Epstein-Barr virus linked to increased risk of multiple sclerosis

Elevated antibody responses to Epstein-Barr virus linked to increased risk of multiple sclerosis

Houston Methodist researchers join national consortium to develop herpesvirus vaccine

Houston Methodist researchers join national consortium to develop herpesvirus vaccine

Exploring the distinct characteristics of Nodular Lymphocyte Predominant Hodgkin Lymphoma

Exploring the distinct characteristics of Nodular Lymphocyte Predominant Hodgkin Lymphoma

Long-term immune changes persist in unvaccinated COVID-19 patients

Long-term immune changes persist in unvaccinated COVID-19 patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.